Drug
Fluvastatin clinical trials
Also written Lescol.
- studies test it
- 34
- open now
- 0
- in phase 3
- 7
- first study started
- 2001
How studies write it
Studies that test it under each name
Brand
Studies by the year they started
34 studies that test it; most in 2004 (5)
| Year | Studies |
|---|---|
| 2001 | 2 |
| 2003 | 4 |
| 2004 | 5 |
| 2005 | 4 |
| 2006 | 4 |
| 2007 | 3 |
| 2008 | 2 |
| 2010 | 1 |
| 2012 | 2 |
| 2014 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 1
- Phase 2
- 7
- Phase 3
- 7
- Phase 4
- 16
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 15 · Other 19
Novartis (9) · Novartis Pharmaceuticals (3) · Sanofi (2) · Mario Negri Institute for Pharmacological Research (2) · University of California, San Francisco (2) · Bader, Ted, M.D. (2) · University of Zurich (1) · Hospital for Special Surgery, New York (1)
Often tested with
Tested in the same studies.
Ezetimibe (4) · Atorvastatin (3) · Pravastatin (3) · Valsartan (3) · Alirocumab (2) · Rosuvastatin (2) · Simvastatin (2) · Lovastatin (2)
Studies
Open first, then newest update. How each study uses Fluvastatin is read from its arms, and is right about nine times in ten.
Testing it · 34
- An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial HypercholesterolemiaCompletedPhase 3SanofiNCT03510884Written as Fluvastatin
- Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport SyndromeCompletedPhase 2Mario Negri Institute for Pharmacological ResearchNCT00309257Written as Benazepril, Valsartan and Fluvastatin
- Drug-Drug Interaction Between Rifampin and FluvastatinCompletedPhase 4University of California, San FranciscoNCT04029584Written as Fluvastatin 20 MG
- An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial HypercholesterolemiaCompletedPhase 3SanofiNCT03510715Written as Fluvastatin
- Prevention of Recurrence and Metastasis in Genetically High-Risk MelanomasWithdrawnEarly Phase 1Case Comprehensive Cancer CenterNCT04285749Written as Fluvastatin
- Randomized Study to Evaluate the Efficacy of Fluvastatin on Inflammatory Markers in Patients With Aortic Stenosis.TerminatedPhase 4AORTICA GroupNCT00404287Written as Fluvastatin
- Effect of Fluvastatin on Brown Fat ActivityCompletedPhase 4University of ZurichNCT03189511Written as Fluvastatin
- Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome PatientsCompletedPhase 2Hospital for Special Surgery, New YorkNCT00674297Written as Fluvastatin
- Preventive Arterial Wall Phenotype and Low-dose Fluvastatin/Valsartan CombinationCompletedNot applicableUniversity Medical Centre LjubljanaNCT03393377Written as fluvastatin 10 mg and valsartan 20 mg
- Novel Window of Opportunity Trial to Evaluate the Impact of Statins to Oppose Prostate CancerCompletedPhase 2University Health Network, TorontoNCT01992042Written as Fluvastatin
- Fluvastatin in Adults With Dislipidemia With History of Muscle ProblemsCompletedPhase 4NovartisNCT00125125Written as Fluvastatin
- Reducing the Overall Risk Level in Patients Suffering From Metabolic SyndromeCompletedPhase 4NovartisNCT00821574Written as Fluvastatin
- Evaluation of the Effect of Fluvastatin 40 mg (b.i.d.) in the Prevention of the Development of Vasculopathy of the Graft in de Novo Renal Transplant Patients TransplantCompletedPhase 4Novartis PharmaceuticalsNCT00565474Written as Fluvastatin
- Trial to Evaluate the Efficacy of Fluvastatin on Certain MarkersCompletedPhase 4NovartisNCT00171262Written as Fluvastatin
- Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary HypercholesterolemiaCompletedPhase 3NovartisNCT00136799Written as Fluvastatin
- Other Effects of Fluvastatin Are Investigated in Patients With Metabolic SyndromeCompletedPhase 4NovartisNCT00138528Written as Fluvastatin
- Efficacy and Safety of Fluvastatin Sodium Extended Release Tablets 80 mg Once Daily in Chinese Patients With Primary Hypercholesterolemia or Mixed DyslipidemiaCompletedPhase 4Novartis PharmaceuticalsNCT01551173Written as Fluvastatin sodium
- A Pilot Trial to Determine the Safety and Efficacy of Fluvastatin in Previous Partial Responders to Pegylated Interferon and Ribivirin in Patients With Genotype 1 Hepatitis CWithdrawnPhase 2University of ChicagoNCT00814606Written as Fluvastatin
- Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for Ductal Carcinoma In Situ or Stage I Breast CancerCompletedPhase 2University of California, San FranciscoNCT00416403Written as fluvastatin sodium
- Fluvastatin AmelIorates aTHerosclerosis StudyStatus unknownPhase 4Beijing Anzhen HospitalNCT01681199Written as Fluvastatin extended release tablet
See all 34 studies that test Fluvastatin →
As the comparator · 1 — what is tested is compared with Fluvastatin
Codes
What other systems call Fluvastatin · ClinicalTrials.gg INT006707
- MeSH (NLM) D000077340FluvastatinConfirmed NLM, Wikidata
- UNII (FDA) 4L066368ASFLUVASTATINConfirmed FDA, NLM, Wikidata
- RxNorm 41127Confirmed FDA, Wikidata
- Wikidata Q106039178(3S,5R)-fluvastatinConfirmed FDA, NLM, Wikidata
- Wikidata Q27147205fluvastatin sodiumConfirmed FDA, NLM, Wikidata
- Wikidata Q417942fluvastatinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61768FluvastatinOne source FDA
- DrugBank DB01095One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077340 | Fluvastatin | Confirmed NLM, Wikidata |
| UNII (FDA) | 4L066368AS | FLUVASTATIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 41127 | — | Confirmed FDA, Wikidata |
| Wikidata | Q106039178 | (3S,5R)-fluvastatin | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27147205 | fluvastatin sodium | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q417942 | fluvastatin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61768 | Fluvastatin | One source FDA |
| DrugBank | DB01095 | — | One source Wikidata |
Also registered as fluvastatin sodium (UNII PYF7O1FV7F · RxNorm 72875).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.